Atlas FDA

InterStim™ Therapy System, Verify™ Evaluation System

FDA premarket approval P080025/S334 · decided 2025-11-26

Approval details

PMA number
P080025
Supplement
S334
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
InterStim™ Therapy System, Verify™ Evaluation System
Generic name
Implanted electrical device intended for treatment of fecal incontinence
Applicant
Medtronic Neuromodulation
Date received
2025-10-16
Decision date
2025-11-26
Days to decision
41 days
Decision code
APPR
Product code
QON
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
a manufacturing site change to add Medtronic Puerto Rico Operations Company, Villalba facility (MVC) as an alternate sterilization site for Neuromodulation/Pelvic Health (NMPH) Implantable Neurostimulators (INS), Drug Delivery Infusion Pumps (SynchroMed), Catheters and Accessories

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23